Both in Pharmaceuticals
Gossamer Bio vs XBiotech
Over the past year GOSS returned −95.1% and XBIT returned −13.1%; their daily moves had a correlation of -0.01.
GOSS −95.1% XBIT −13.1%Growth of $1, one year, split-adjusted
| Metric | GOSS | XBIT |
|---|---|---|
| Price | $9.28 | $1.99 |
| Market cap | $56.8M | $60.7M |
| Today | −1.80% | +3.65% |
| 1 month | −12.9% | −8.7% |
| 6 months | −65.5% | −22.0% |
| Year to date | −96.3% | −16.7% |
| 1 year | −95.3% | −15.3% |
| Revenue growth (YoY) | −19.6% | — |
| Gross margin | 100.0% | — |
| Net margin | 182.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 1.1× | — |
| Net cash | $20.9M | $109.5M |
| Dividend yield | — | — |
| Volatility (60d) | 1,265.9% | 36.1% |
| Short % of float | 24.9% | 1.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).